These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38127922)

  • 61. Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
    Gouma S; Zost SJ; Parkhouse K; Branche A; Topham DJ; Cobey S; Hensley SE
    Clin Infect Dis; 2020 Sep; 71(6):1447-1453. PubMed ID: 31598646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
    Wang W; Butler EN; Veguilla V; Vassell R; Thomas JT; Moos M; Ye Z; Hancock K; Weiss CD
    J Virol Methods; 2008 Nov; 153(2):111-9. PubMed ID: 18722473
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.
    Wang J; Li D; Perry S; Hilchey SP; Wiltse A; Treanor JJ; Sangster MY; Zand MS
    mBio; 2021 Aug; 12(4):e0044921. PubMed ID: 34225490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
    McCarthy KR; Lee J; Watanabe A; Kuraoka M; Robinson-McCarthy LR; Georgiou G; Kelsoe G; Harrison SC
    mBio; 2021 Jun; 12(3):e0114421. PubMed ID: 34060327
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
    Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
    Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y
    Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.
    Wei CJ; Boyington JC; Dai K; Houser KV; Pearce MB; Kong WP; Yang ZY; Tumpey TM; Nabel GJ
    Sci Transl Med; 2010 Mar; 2(24):24ra21. PubMed ID: 20375007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unique binding pattern for a lineage of human antibodies with broad reactivity against influenza A virus.
    Sun X; Liu C; Lu X; Ling Z; Yi C; Zhang Z; Li Z; Jin M; Wang W; Tang S; Wang F; Wang F; Wangmo S; Chen S; Li L; Ma L; Zhang Y; Yang Z; Dong X; Qian Z; Ding J; Wang D; Cong Y; Sun B
    Nat Commun; 2022 May; 13(1):2378. PubMed ID: 35501328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.
    Tan L; Lu H; Zhang D; Tian M; Hu B; Wang Z; Jin N
    Virol J; 2010 Dec; 7():363. PubMed ID: 21134292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model.
    Vergara-Alert J; Argilaguet JM; Busquets N; Ballester M; Martín-Valls GE; Rivas R; López-Soria S; Solanes D; Majó N; Segalés J; Veljkovic V; Rodríguez F; Darji A
    PLoS One; 2012; 7(7):e40524. PubMed ID: 22815759
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.
    Skarlupka AL; Owino SO; Suzuki-Williams LP; Crevar CJ; Carter DM; Ross TM
    Hum Vaccin Immunother; 2019; 15(9):2013-2029. PubMed ID: 31448974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An epitope-enriched immunogen expands responses to a conserved viral site.
    Caradonna TM; Ronsard L; Yousif AS; Windsor IW; Hecht R; Bracamonte-Moreno T; Roffler AA; Maron MJ; Maurer DP; Feldman J; Marchiori E; Barnes RM; Rohrer D; Lonberg N; Oguin TH; Sempowski GD; Kepler TB; Kuraoka M; Lingwood D; Schmidt AG
    Cell Rep; 2022 Nov; 41(6):111628. PubMed ID: 36351401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.